Belgium vs Canada: Proportion of isolates with decreased susceptibility or resistance
Belgium
0.6
in 2020
Canada
1.4
in 2020
Belgium rank
10th
Canada rank
7th
Proportion of isolates with decreased susceptibility or resistance over time
- Belgium
- Canada
How they compare
Canada currently reports 1.4 against 0.6 in Belgium, a difference of 0.8.
That makes Canada's figure about 2.3 times Belgium's.
Across all 10 years both countries report, Canada has been ahead every year.
Belgium ranks 10th and Canada ranks 7th of 52 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belgium | Canada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 3.09 | 3.09 | Canada |
| 2010s | 0 | 3.6 | 3.6 | Canada |
| 2020s | 0.6 | 1.4 | 0.8 | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Belgium or Canada?
- Canada, at 1.4 against 0.6 in Belgium as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Belgium and Canada?
- 0.8, with Canada ahead.
- How many years of comparable data are there for Belgium and Canada?
- 10 years are reported by both, from 2009 to 2020.
- How do Belgium and Canada rank globally for proportion of isolates with decreased susceptibility or resistance?
- Belgium ranks 10th and Canada ranks 7th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.